Özet
Following publication of the original article [1], the authors identified an error in the author names of Mustafa Erman, Bivas Biswas, Pongwut Danchaivijitr, Lingwu Chen and Chandrasekhar Chikatapu. The given names and family names were erroneously transposed. Further to this, figure 1 has been updated. The line colors in “C” section for “Poor” and “Unknown” have been changed to align with Figure B and legend to match the line colors. The author group has been updated above and the original article [1] has been corrected.
| Orijinal dil | İngilizce |
|---|---|
| Makale numarası | 1191 |
| Dergi | BMC Cancer |
| Hacim | 21 |
| Basın numarası | 1 |
| DOI'lar |
|
| Yayın durumu | Yayınlandı - Ara 2021 |
BM SKH
Bu sonuç, aşağıdaki Sürdürülebilir Kalkınma Hedefine/Hedeflerine katkıda bulunur
-
SKH 3 Sağlık ve Kaliteli Yaşam
Parmak izi
Correction to: Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study (BMC Cancer, (2021), 21, 1, (1021), 10.1186/s12885-021-08738-z)' araştırma başlıklarına git. Birlikte benzersiz bir parmak izi oluştururlar.Bundan alıntı yap
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver